4//SEC Filing
Hemrajani Rekha 4
Accession 0000905148-25-003155
CIK 0001287098other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:12 PM ET
Size
5.0 KB
Accession
0000905148-25-003155
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Hemrajani Rekha
Director
Transactions
- Sale
Common Stock
2025-06-25$2.09/sh−10,684$22,378→ 39,893 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001771213
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:12 PM ET
- Size
- 5.0 KB